GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medeze Group PCL (BKK:MEDEZE) » Definitions » Beta

Medeze Group PCL (BKK:MEDEZE) Beta : N/A (As of Dec. 15, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Medeze Group PCL Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-12-15), Medeze Group PCL's Beta is Not available.


Medeze Group PCL Beta Historical Data

The historical data trend for Medeze Group PCL's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeze Group PCL Beta Chart

Medeze Group PCL Annual Data
Trend
Beta

Medeze Group PCL Quarterly Data
Mar23 Jun23 Mar24 Jun24
Beta - - - -

Competitive Comparison of Medeze Group PCL's Beta

For the Medical Care Facilities subindustry, Medeze Group PCL's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medeze Group PCL's Beta Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medeze Group PCL's Beta distribution charts can be found below:

* The bar in red indicates where Medeze Group PCL's Beta falls into.



Medeze Group PCL Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Medeze Group PCL  (BKK:MEDEZE) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Medeze Group PCL Beta Related Terms

Thank you for viewing the detailed overview of Medeze Group PCL's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Medeze Group PCL Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Phutthamonthon Sai 4 Road, 28/9 Moo 8, Krathum Lom, Sam Phran, Nakhon Pathom, THA, 73220
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation, and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment.

Medeze Group PCL Headlines

No Headlines